Neuren Pharmaceuticals | NEU - Операционный доход

Биржевая цена
11.78
Изменение за день
-0.07 -0.59%
Ежемесячно
-14.45%
Ежегодный
-3.92%
Q1 прогноз
11.52




Операционный доход Изменить Дата
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Avita Medical AUD -10.41M 742K 2025-12
Clinuvel Pharmaceuticals AUD 13.51M 15.95M 2025-12
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Genetic Signatures AUD -6.34M 1.67M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Medical Developments International AUD -36K 444K 2025-12
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Organon & Co USD 388M 62M 2025-09
Paradigm Biopharmaceuticals AUD -21.57M 13.07M 2025-12
PYC Therapeutics AUD -22.59M 9.12M 2025-12
Starpharma Holdings AUD -873K 1.43M 2025-12
Tectonic Therapeutic USD -21.52M 374K 2025-12
Telix Pharmaceuticals AUD 8.04M 3.21M 2025-12
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 16.77M 10.04M 2025-12